Nailbot Named CES 2022 Innovation Awards Honoree via Business Wire

25 January 2022

CARLSBAD, Calif.–(BUSINESS WIRE)–Preemadonna today announced that it has been awarded a CES® Innovation Awards Honoree for its flagship product Nailbot, a patented and connected, at-home manicure system that prints instant nail art and photos from your smartphone onto your fingernails. The announcement was made in conjunction with the Consumer Electronic Show 2022 (CES 2022), the world’s most influential technology event, happening January 5-7 in Las Vegas, NV and digitally.

“We are humbled and thrilled that Nailbot has been awarded this prestigious honor from the technology community. This award represents industry validation of our technical journey to bring affordable and accessible experiences to power creative expression through nail and body art,” says Pree Walia, Founder of Preemadonna and lead inventor of Nailbot.

The CES® Innovation Award honor comes at the heels of a sold-out Drop 1, which shipped Nailbot printers to early crowdfunding backers last December. Drop 2 of Nailbot is available now for pre-order from Nailbot.com for $199.99 (regularly priced at $299.99).

This Drop 2 pre-order launch and CES Innovation Award are the culmination of twelve months of progress since Preemadonna closed their seed round led by Halogen Ventures with participation from Version One Ventures, the Amazon Alexa Fund and high-profile angels and entrepreneurs.

In 2022, the company will continue to expand by scaling operations to fulfill demand and launching ambassador and mentorship programs to support and grow their community of creators, makers, and artists.

Read more…

By Nailbot – January 05, 2022


Save time and easily find the methods and the testing suppliers to substantiate your actives and cosmetics claims.

Don't miss our weekly newsletter

* Receive regular news of what's moving the world of preclinical and clinical testing of the Beauty industry

Save time and easily find the methods and test providers to validate your product claims.